Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1976 Aug;39(8):810–816. doi: 10.1136/jnnp.39.8.810

Hypertrophy of the branchial muscles. A case with unusual features.

C D Lambert, J R Young
PMCID: PMC492456  PMID: 956867

Abstract

A detailed morphological and histochemical description of pathological changes previously unreported in hypertrophy of the masseter muscle is presented. The patient differed from earlier cases in reacting adversely to anaesthetic agents.

Full text

PDF
810

Images in this article

810Image
on p.810
812Image
on p.812
813Image
on p.813
813Image
on p.813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askanas V., Shafiq S. A., Milhorat A. T. Histochemistry of cultured aneural chick muscle. Morphological maturation without differentiation of fiber types. Exp Neurol. 1972 Oct;37(1):218–230. doi: 10.1016/0014-4886(72)90238-5. [DOI] [PubMed] [Google Scholar]
  2. Beldavs J., Small V., Cooper D. A., Britt B. A. Postoperative malignant hyperthermia: a case report. Can Anaesth Soc J. 1971 Mar;18(2):202–212. doi: 10.1007/BF03025451. [DOI] [PubMed] [Google Scholar]
  3. Britt B. A., Kalow W. Malignant hyperthermia: a statistical review. Can Anaesth Soc J. 1970 Jul;17(4):293–315. doi: 10.1007/BF03004694. [DOI] [PubMed] [Google Scholar]
  4. Brooke M. H., Engel W. K. The histologic diagnosis of neuromuscular diseases: a review of 79 biopsies. Arch Phys Med Rehabil. 1966 Mar;47(3):99–121. [PubMed] [Google Scholar]
  5. Cooperman L. H. Succinylcholine-induced hyperkalemia in neuromuscular disease. JAMA. 1970 Sep 14;213(11):1867–1871. [PubMed] [Google Scholar]
  6. Ellis F. R., Keaney N. P., Harriman D. G., Sumner D. W., Kyei-Mensah K., Tyrrell J. H., Hargreaves J. B., Parikh R. K., Mulrooney P. L. Screening for malignant hyperpyrexia. Br Med J. 1972 Sep 2;3(5826):559–561. doi: 10.1136/bmj.3.5826.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ellis F. R. Malignant hyperpyrexia. Anaesthesia. 1973 May;28(3):245–252. [PubMed] [Google Scholar]
  8. Engel W. K. Focal myopathic changes produced by electromyographic and hypodermic needles. "Needle myopathy". Arch Neurol. 1967 May;16(5):509–511. doi: 10.1001/archneur.1967.00470230061008. [DOI] [PubMed] [Google Scholar]
  9. GONATAS N. K., PEREZ M. C., SHY G. M., EVANGELISTA I. CENTRAL "CORE" DISEASE OF SKELETAL MUSCLE. ULTRASTRUCTURAL AND CYTOCHEMICAL OBSERVATIONS IN TWO CASES. Am J Pathol. 1965 Sep;47:503–524. [PMC free article] [PubMed] [Google Scholar]
  10. Harriman D. G., Sumner D. W., Ellis F. R. Malignant hyperpyrexia myopathy. Q J Med. 1973 Oct;42(168):639–664. [PubMed] [Google Scholar]
  11. Isaacs H., Frere G., Mitchell J. Histological, histochemical and ultramicroscopic findings in muscle biopsies from carriers of the trait for malignant hyperpyrexia. Br J Anaesth. 1973 Aug;45(8):860–868. doi: 10.1093/bja/45.8.860. [DOI] [PubMed] [Google Scholar]
  12. Jensen K., Bennike K. A., Hanel H. K., Olesen H. Myoglobinuria following anaesthesia including suxamethonium. Br J Anaesth. 1968 May;40(5):329–334. doi: 10.1093/bja/40.5.329. [DOI] [PubMed] [Google Scholar]
  13. Kalow W., Britt B. A., Terreau M. E., Haist C. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet. 1970 Oct 31;2(7679):895–898. doi: 10.1016/s0140-6736(70)92069-6. [DOI] [PubMed] [Google Scholar]
  14. Karpati G., Engel W. K. Neuronal trophic function. A new aspect demonstrated histochemically in developing soleus muscle. Arch Neurol. 1967 Nov;17(5):542–545. doi: 10.1001/archneur.1967.00470290096012. [DOI] [PubMed] [Google Scholar]
  15. Karpati G., Engel W. K. Transformation of the histochemical profile of skeletal muscle by "foreign" innervation. Nature. 1967 Sep 30;215(5109):1509–1510. doi: 10.1038/2151509a0. [DOI] [PubMed] [Google Scholar]
  16. King J. O., Denborough M. A., Zapf P. W. Inheritance of malignant hyperpyrexia. Lancet. 1972 Feb 12;1(7746):365–370. doi: 10.1016/s0140-6736(72)92854-1. [DOI] [PubMed] [Google Scholar]
  17. Lambert C. D. Uniform muscle histochemistry: a clinical and biopsy study. Trans Am Neurol Assoc. 1974;99:120–125. [PubMed] [Google Scholar]
  18. Mancall E. L., Patel A. N., Hirschhorn A. M. Hypertrophic branchial myopathy. Idiopathic enlargement of the masticatory muscles as a neglected myopathic disorder. Neurology. 1974 Dec;24(12):1166–1170. doi: 10.1212/wnl.24.12.1166. [DOI] [PubMed] [Google Scholar]
  19. Moulds R. F., Denborough M. A. Identification of susceptibility to malignant hyperpyrexia. Br Med J. 1974 May 4;2(5913):245–247. doi: 10.1136/bmj.2.5913.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nienhuis A. W., Coleman R. F., Brown W. J., Munsat T. L., Pearson C. M. Nemaline myopathy. A histopathologic and histochemical study. Am J Clin Pathol. 1967 Jul;48(1):1–13. doi: 10.1093/ajcp/48.1.1. [DOI] [PubMed] [Google Scholar]
  21. Paakkari I., Mumenthaler M. Needle Myopathy--An Experimental Study. J Neurol. 1974;208(2):133–138. doi: 10.1007/BF00312509. [DOI] [PubMed] [Google Scholar]
  22. Ratzlaff E. H., Jenkins L. C. Malignant hyperthermia: a case report of successful management. Can Anaesth Soc J. 1972 Sep;19(5):549–556. doi: 10.1007/BF03005815. [DOI] [PubMed] [Google Scholar]
  23. Relton J. E., Britt B. A., Steward D. J. Malignant hyperpyrexia. Br J Anaesth. 1973 Mar;45(3):269–275. doi: 10.1093/bja/45.3.269. [DOI] [PubMed] [Google Scholar]
  24. Relton J. E., Creighton R. E., Conn A. W. Fulminant hyperpyrexia associated with anaesthesia. Anaesthesia. 1968 Apr;23(2):253–258. doi: 10.1111/j.1365-2044.1968.tb00048.x. [DOI] [PubMed] [Google Scholar]
  25. Relton J. E., Steward D. J., Creighton R. E., Britt B. A. [Malignant hyperpyrexia: a therapeutic and investigative regimen]. Can Anaesth Soc J. 1972 Mar;19(2):200–205. doi: 10.1007/BF03005051. [DOI] [PubMed] [Google Scholar]
  26. Ringqvist M. Size and distribution of histochemical fibre types in masseter muscle of adults with different states of occlusion. J Neurol Sci. 1974 Aug;22(4):429–438. doi: 10.1016/0022-510x(74)90079-3. [DOI] [PubMed] [Google Scholar]
  27. Ryan J. F., Papper E. M. Malignant fever during and following anesthesia. Anesthesiology. 1970 Mar;32(3):196–201. doi: 10.1097/00000542-197003000-00004. [DOI] [PubMed] [Google Scholar]
  28. Steers A. J., Tallack J. A., Thompson D. E. Fulminating hyperpyrexia during anaesthesia in a member of a myopathic family. Br Med J. 1970 May 9;2(5705):341–343. doi: 10.1136/bmj.2.5705.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Takahashi T., Takasaki M., Namiki A., Dohi S. Rise in serum creatine phosphokinase associated with agents used in anaesthesia. Br J Anaesth. 1973 Feb;45(2):185–190. [PubMed] [Google Scholar]
  30. Tammisto T., Airaksinen M. Increase of creatine kinase activity in serum as sign of muscular injury caused by intermittently administred suxamethonium during halothane anaesthesia. Br J Anaesth. 1966 Jul;38(7):510–515. doi: 10.1093/bja/38.7.510. [DOI] [PubMed] [Google Scholar]
  31. Thiel R. E. The myotonic response to suxamethonium. Br J Anaesth. 1967 Oct;39(10):815–821. doi: 10.1093/bja/39.10.815. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES